(EMAILWIRE.COM, January 08, 2019 ) Global Veterinary/Animal Vaccines Industry was valued at USD 6.60 Billion in the year 2017. Global Veterinary/Animal Vaccines Industry is further estimated to grow at a CAGR of 6.2 % from 2019 to reach USD 10.57 Billion by the year 2025. European region holds the highest Industry share in 2017 and Asia Pacific Industry is considered as the fastest growing Industry in the forecasted period. At a country level, Germany and France are projected to grow strongly in the coming years.
Major market players in Veterinary/Animal Vaccines Industry are Merck Animal Health, Boehringer Ingelheim, Bioniche Animal Health, Merial (Sanofi), Virbac, Zoetis (Pfizer), Bayer Healthcare, Elcano Animal Health, Hipra, China Animal Husbandry, and brief information of 10 companies will be provided in the report. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
Get Free Sample Report@ http://www.qurateresearch.com/report/sample/HnM/QBI-GRS-HnM-134330
SWOT Analysis of Veterinary/Animal Vaccines Industry:
Strength:
Increasing research and investments related activities
Rising Incidence of Zoonotic Diseases
Weakness:
Availability and high cost of the vaccine
Opportunities:
Technological advancements
Threats:
Government intervention in the distribution channel
The Global Veterinary/Animal Vaccines is segmented as by-products, by Technology, by diseases, and by region. On the basis of products, the Industry is segmented as Livestock Vaccines, Companion Animal Vaccines, Porcine Vaccines, Equine Vaccines, Poultry Vaccines, Aquaculture Vaccines and Other Animal Vaccines of which Porcine Veterinary/Animal Vaccines holds the highest Industry share. On the basis of technology Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, Conjugate Vaccines, Companies of which Live Attenuated Vaccines expected to form the largest technological segment.
Enquiry about Report@ http://www.qurateresearch.com/report/enquiry/HnM/QBI-GRS-HnM-134330
Veterinary/Animal Vaccines Industry Segmentation:
By Technology
Inactivated Vaccines
Live Attenuated Vaccines
Subunit Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
Conjugate Vaccines
By Diseases
Poultry Diseases
Companion Animal Disease
Livestock Diseases
Aquaculture Diseases
Other Diseases
Livestock Vaccines
Companion Animal Vaccines
Porcine Vaccines
Equine Vaccines
Poultry Vaccines
Aquaculture Vaccines
Other Animal Vaccines
Purchase Report@ http://www.qurateresearch.com/report/buy/HnM/QBI-GRS-HnM-134330/
By Region
North America
o USA
o Canada
Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
APAC
o China
o India
o Japan
o Rest of Asia-Pacific
RoW
o Latin America
o Middle East & Africa
Nehal Chinoy
+919881074592
nehal@qurateresearch.com
Source: EmailWire.Com 
